Stimuli-responsive particles encapsulating a gas and methods of use

US11147890B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11147890-B2
Application numberUS-201816489541-A
CountryUS
Kind codeB2
Filing dateFeb 28, 2018
Priority dateFeb 28, 2017
Publication dateOct 19, 2021
Grant dateOct 19, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are various gas-filled particles having a stimuli-responsive shell encapsulating the gas. The stimuli-responsive shell comprises one or more release triggers. Compositions for medical or non-medical applications, methods of use and treatment, and methods of preparation are also described.

First claim

Opening claim text (preview).

We claim: 1. A composition comprising a stable particle having a shell surrounding a gas core, wherein the shell includes a release trigger, wherein the release trigger is a pH-responsive trigger, wherein the shell comprises succinylated and acetylated dextran (Dex-Ac-Suc), and wherein the succinyl moiety of the Dex-Ac-Suc is the pH-responsive trigger. 2. The composition of claim 1 , wherein the shell comprises nanoparticle aggregates. 3. The composition of claim 2 , wherein the stable particle is formed by nanoprecipitation of an amphiphilic polymer comprising the release trigger at an air/liquid interface to form the shell. 4. The composition of claim 3 , wherein the amphiphilic polymer comprises acetylated dextran (Dex-Ac). 5. The composition of claim 2 , wherein the nanoparticle aggregates comprise primary particles, each primary particle having an average diameter of 50 nm or less, and wherein the shell has a thickness of 10-280 nm. 6. The composition of claim 1 , wherein the stable particle is formed by nanoprecipitation of an amphiphilic polymer comprising the release trigger at an air/liquid interface to form the shell.

Assignees

Inventors

Classifications

  • Medicinal preparations containing inorganic active ingredients · CPC title

  • Drugs for disorders of the blood or the extracellular fluid · CPC title

  • Solutions {(composition of solutions A61K47/00)} · CPC title

  • Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin · CPC title

  • A61K49/223Primary

    Microbubbles, hollow microspheres, free gas bubbles, gas microspheres · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11147890B2 cover?
Provided herein are various gas-filled particles having a stimuli-responsive shell encapsulating the gas. The stimuli-responsive shell comprises one or more release triggers. Compositions for medical or non-medical applications, methods of use and treatment, and methods of preparation are also described.
Who is the assignee on this patent?
Childrens Medical Center
What technology area does this patent fall under?
Primary CPC classification A61K49/223. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).